Whitley, R. J., & Roizman, B. (2001). Herpes simplex virus infections. The Lancet, 357(9267), 1513-1518.
Looker, K. J., et al. (2015). Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS ONE, 10(10), e0140765.
James, C., et al. (2020). Herpes simplex virus: An update on treatment and prevention. Expert Opinion on Pharmacotherapy, 21(4), 383-392.
Johnston, C., et al. (2017). Molecular and clinical aspects of herpes simplex virus latency, reactivation, and novel treatment approaches. The Journal of Clinical Investigation, 127(8), 2880-2898.
Koelle, D. M., & Corey, L. (2008). Herpes simplex: Insights on pathogenesis and possible vaccines. Annual Review of Medicine, 59, 381-395.
Tronstein, E., et al. (2011). Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons. JAMA, 305(14), 1441-1449.
Roizman, B., & Whitley, R. J. (2013). The nine ages of herpes simplex virus. Herpesviridae, 4(1), 1-12.
Schiffer, J. T., & Corey, L. (2013). Rapid host immune response and viral dynamics in herpes simplex virus-2 infection. Nature Medicine, 19(3), 280-290.
Knipe, D. M., & Cliffe, A. R. (2008). Chromatin control of herpes simplex virus lytic and latent infection. Nature Reviews Microbiology, 6(3), 211-221.
Piret, J., & Boivin, G. (2020). Immunomodulatory strategies in herpes simplex virus encephalitis. Clinical Microbiology Reviews, 33(1), e00105-19.